The Knierman group characterized 11 alpha-synuclein proteoforms with truncations or PTMs (e.g., phosphorylation) across Parkinson's disease tissues and normal brain tissues.158 The proteoform carrying serine-129 phosphorylation, a widely accepted pathology-associated modification, presented significant differences between disease tissues and controls. Here, SNCA is linked to Parkinson disease.